Pfizer Oncology Head Charles Baum: An Interview With “The Pink Sheet”

In an interview with "The Pink Sheet," Charles Baum highlights several of Pfizer's late-stage oncology drugs in development, including axitinib in pancreatic cancer and tremelimumab for metastatic melanoma, and discusses the way Pfizer's R&D strategy for oncology is evolving. Baum is VP and head of the Oncology Therapeutic Area at Pfizer Global Research. Prior to joining Pfizer in 2003 he was senior director of oncology at Schering-Plough.